Omnicell (OMCL) Cash & Equivalents (2016 - 2025)
Omnicell (OMCL) has disclosed Cash & Equivalents for 16 consecutive years, with $131.1 million as the latest value for Q3 2025.
- On a quarterly basis, Cash & Equivalents fell 77.03% to $131.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $131.1 million, a 77.03% decrease, with the full-year FY2024 number at $369.2 million, down 21.11% from a year prior.
- Cash & Equivalents was $131.1 million for Q3 2025 at Omnicell, down from $352.2 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $614.2 million in Q2 2021 to a low of $131.1 million in Q3 2025.
- A 5-year average of $399.4 million and a median of $369.2 million in 2024 define the central range for Cash & Equivalents.
- Peak YoY movement for Cash & Equivalents: soared 426.57% in 2021, then crashed 77.03% in 2025.
- Omnicell's Cash & Equivalents stood at $349.1 million in 2021, then dropped by 5.35% to $330.4 million in 2022, then surged by 41.65% to $468.0 million in 2023, then dropped by 21.11% to $369.2 million in 2024, then plummeted by 64.49% to $131.1 million in 2025.
- Per Business Quant, the three most recent readings for OMCL's Cash & Equivalents are $131.1 million (Q3 2025), $352.2 million (Q2 2025), and $341.6 million (Q1 2025).